Assembly Biosciences, Inc.
ASMB
$10.70
$0.171.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -40.18M | -40.80M | -45.61M | -51.36M | -61.23M |
| Total Depreciation and Amortization | 129.00K | 181.00K | 264.00K | 358.00K | 450.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 879.00K | 1.40M | 2.73M | 4.38M | 7.18M |
| Change in Net Operating Assets | -11.95M | 62.16M | 66.95M | 74.43M | 76.34M |
| Cash from Operations | -51.12M | 22.94M | 24.33M | 27.81M | 22.74M |
| Capital Expenditure | -28.00K | -99.00K | -235.00K | -269.00K | -255.00K |
| Sale of Property, Plant, and Equipment | -- | 24.00K | 24.00K | 24.00K | 24.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 40.20M | -42.71M | -48.18M | -61.62M | -68.91M |
| Cash from Investing | 40.17M | -42.79M | -48.39M | -61.87M | -69.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 29.45M | 21.65M | 21.65M | 9.33M | 13.82M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 29.45M | 21.65M | 21.65M | 9.33M | 13.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.50M | 1.80M | -2.42M | -24.73M | -32.58M |